Lv4
678 积分 2025-08-11 加入
Isatuximab, carfilzomib, and dexamethasone in relapsed multiple myeloma (IKEMA): a multicentre, open-label, randomised phase 3 trial
13小时前
已完结
Refractory Systemic Lupus Erythematosus: Identification and Pharmacological Management
2个月前
已完结
Anti-BCMA/GPRC5D bispecific CAR T cells in patients with relapsed or refractory multiple myeloma: a single-arm, single-centre, phase 1 trial
3个月前
已完结
Global trends in melanoma burden: A comprehensive analysis from the Global Burden of Disease Study, 1990-2021
4个月前
已完结
International Myeloma Working Group immunotherapy committee consensus guidelines and recommendations for optimal use of T-cell-engaging bispecific antibodies in multiple myeloma
4个月前
已完结
2022年WHO骨髓增殖性肿瘤、骨髓增生异常性/骨髓增殖性肿瘤诊断及分类
4个月前
已完结
Epidemiology of myositis
5个月前
已完结
Pathogenesis of systemic sclerosis: an integrative review of recent advances
6个月前
已完结
Systemic sclerosis
6个月前
已完结
[Recommendations for diagnosis and treatment of systemic sclerosis in China]
6个月前
已完结
皖公网安备34019202002308
